Skåne University Hospital

Academic/Hospital

Also known as: Department of Endocrinology, Skåne University Hospital, Malmö, Sweden | Department of Internal Medicine, Skåne University Hospital, Malmö | Department of Oncology, Skåne University Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 31, 2020

Last known activity

Jan 4, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 4 trials)

Phase 3 (6 own, 0 via acquisition)

polatuzumab vedotin
prednisone
doxorubicin
vincristine
cyclophosphamide
rituximab

Phase 2 (2 own, 0 via acquisition)

acalabrutinib
emilimogene sigulactibac

Other trials (1 own, 0 via acquisition)

sucrose

Indications

Studied for

Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse

Recent trials (4)

NCT05688826OfficialN/AJan 4, 2023
NCT05608187OfficialPhase 2Sep 26, 2022
NCT05214183Overall official - principal investigatorPhase 2Dec 15, 2021
NCT04332822Overall official - principal investigatorPhase 3Mar 31, 2020

Details

Last known activity: Jan 4, 2023